Compare DSP Nifty Healthcare Index Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
DSP Nifty Healthcare Index Fund
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Risk
Very High
Very High
Rating
-
5.0
Min SIP Amount
₹100
₹100
Expense Ratio
1.05
2.09
NAV
₹11.89
₹47.50
Fund Started
02 Jun 2025
25 Jun 2018
Fund Size
₹21.89 Cr
₹6624.58 Cr
Exit Load
-
Exit load of 1% if redeemed within 15 days.
1 Year
10.51%
5.43%
3 Year
-
23.11%
5 Year
-
15.81%
Equity
99.94%
96.05%
Cash
0.06%
3.95%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 18.13% |
Apollo Hospitals Enterprise Ltd. | 8.21% |
Max Healthcare Institute Ltd. | 7.73% |
Divi's Laboratories Ltd. | 7.69% |
Dr. Reddy's Laboratories Ltd. | 7.61% |
Cipla Ltd. | 7.58% |
Laurus Labs Ltd. | 5.43% |
Lupin Ltd. | 5.40% |
Fortis Healthcare Ltd. | 4.58% |
Torrent Pharmaceuticals Ltd. | 4.46% |
Sun Pharmaceutical Industries Ltd. | 12.20% |
Dr. Reddy's Laboratories Ltd. | 8.22% |
Mankind Pharma Ltd. | 6.98% |
Cipla Ltd. | 6.67% |
Alkem Laboratories Ltd. | 5.67% |
Divi's Laboratories Ltd. | 5.57% |
Cohance Lifesciences Ltd. | 4.31% |
Medplus Health Services Ltd. | 3.66% |
Max Healthcare Institute Ltd. | 3.10% |
Syngene International Ltd. | 2.89% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate returns that are commensurate with the performance of the Nifty Healthcare Index, subject to tracking error.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
02 Jun 2025
25 Jun 2018
